-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Transcode Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2020 to Q4 2024.
- Transcode Therapeutics, Inc. Interest Expense for the quarter ending December 31, 2024 was $1.83K, a 89.4% decline year-over-year.
- Transcode Therapeutics, Inc. Interest Expense for the twelve months ending December 31, 2024 was $26.8K, a 52% decline year-over-year.
- Transcode Therapeutics, Inc. annual Interest Expense for 2024 was $26.8K, a 52% decline from 2023.
- Transcode Therapeutics, Inc. annual Interest Expense for 2023 was $55.9K, a 74.8% increase from 2022.
- Transcode Therapeutics, Inc. annual Interest Expense for 2022 was $32K, a 66.4% decline from 2021.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)